After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
A TauRx Therapeutics drug designed to dissolve tangles of a protein called tau in the brain failed to slow cognitive and functional declines of Alzheimer's patients compared with a control.
After Biogen’s (BIIB) CEO George Scangos announced he would step down, Leerink surmised the company is looking to sell.
The company sans CEO Scangos needs to do some type of deal in the coming months.
Biogen's announcement that CEO George Scangos would step down as head of the biotech company marks the latest company to see its chief leave the perch this year.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.